microRNA Expression Pattern Modulates Temozolomide Response in GBM Tumors with Cancer Stem Cells

[1]  Taosheng Chen,et al.  miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells , 2014, Oncogene.

[2]  G. Packham,et al.  miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance. , 2013, Cancer research.

[3]  A. Shiras,et al.  MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells. , 2013, Neuro-oncology.

[4]  Keith L Ligon,et al.  Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity , 2013, Molecular therapy. Nucleic acids.

[5]  G. Reifenberger,et al.  Molecular neuro-oncology in clinical practice: a new horizon. , 2013, The Lancet. Oncology.

[6]  K. Sai,et al.  miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1 , 2013, Cancer Chemotherapy and Pharmacology.

[7]  R. Agami,et al.  Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer , 2013, Cell cycle.

[8]  Giovanni Broggi,et al.  CD133 Is Essential for Glioblastoma Stem Cell Maintenance , 2013, Stem cells.

[9]  T. Mikkelsen,et al.  MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1 , 2013, Oncotarget.

[10]  O. Kallioniemi,et al.  Functional Profiling of Precursor MicroRNAs Identifies MicroRNAs Essential for Glioma Proliferation , 2013, PloS one.

[11]  N. Chang,et al.  Assessing Current Therapeutic Approaches to Decode Potential Resistance Mechanisms in Glioblastomas , 2013, Front. Oncol..

[12]  Daming Zhang,et al.  MicroRNA-153 is tumor suppressive in glioblastoma stem cells , 2013, Molecular Biology Reports.

[13]  T. Mikkelsen,et al.  MicroRNA-145 Is Downregulated in Glial Tumors and Regulates Glioma Cell Migration by Targeting Connective Tissue Growth Factor , 2013, PloS one.

[14]  Yuefeng Li,et al.  miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1. , 2013, Acta biochimica et biophysica Sinica.

[15]  L. C. Hinske,et al.  In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing , 2013, Acta Neuropathologica.

[16]  D. Schiff,et al.  Oncogenic effects of miR-10b in glioblastoma stem cells , 2013, Journal of Neuro-Oncology.

[17]  P. Álvarez,et al.  MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy , 2012, Journal of Translational Medicine.

[18]  Yuanfang Ma,et al.  Glucocorticoid regulation of a novel HPV–E6–p53–miR‐145 pathway modulates invasion and therapy resistance of cervical cancer cells , 2012, The Journal of pathology.

[19]  R. Scienza,et al.  BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression , 2012, Cell Death and Disease.

[20]  Jian-yong Li,et al.  miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. , 2012, Carcinogenesis.

[21]  B. Tunca,et al.  Olea europaea leaf extract alters microRNA expression in human glioblastoma cells , 2012, Journal of Cancer Research and Clinical Oncology.

[22]  R. Boot-Handford,et al.  The expression and function of microRNAs in chondrogenesis and osteoarthritis. , 2012, Arthritis and rheumatism.

[23]  K. Guo,et al.  miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. , 2012, Biochemical and biophysical research communications.

[24]  L. Toussaint,et al.  Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines , 2012, BMC Cancer.

[25]  Dimitris Anastassiou,et al.  A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma , 2012, PloS one.

[26]  K. Mimori,et al.  MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells , 2012, Annals of Surgical Oncology.

[27]  K. Tachibana,et al.  MEK‐ERK Signaling Dictates DNA‐Repair Gene MGMT Expression and Temozolomide Resistance of Stem‐Like Glioblastoma Cells via the MDM2‐p53 Axis , 2011, Stem cells.

[28]  Jhi-Joung Wang,et al.  Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. , 2011, Oncology reports.

[29]  R. McLendon,et al.  Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells , 2011, PloS one.

[30]  Nuran Bayram,et al.  The Promoter Hypermethylation Status of GATA6, MGMT, and FHIT in Glioblastoma , 2011, Cellular and Molecular Neurobiology.

[31]  Stefano Volinia,et al.  miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. , 2011, Blood.

[32]  Hye-Min Jeon,et al.  ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2. , 2011, Cancer research.

[33]  Keun-Hwa Jung,et al.  Let-7 microRNA inhibits the proliferation of human glioblastoma cells , 2011, Journal of Neuro-Oncology.

[34]  Xia Shan,et al.  miR‐181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines , 2010, International journal of cancer.

[35]  Yingyi Wang,et al.  MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells , 2010, Journal of biomedical research.

[36]  L. Denaro,et al.  Interaction of Hypoxia‐Inducible Factor‐1α and Notch Signaling Regulates Medulloblastoma Precursor Proliferation and Fate , 2010, Stem cells.

[37]  Keiji Suzuki,et al.  miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. , 2010, Cancer letters.

[38]  R. Scienza,et al.  Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma , 2010, Stem cells.

[39]  M. Poruchynsky,et al.  Potent inhibition of tumoral hypoxia-inducible factor 1α by albendazole , 2010, BMC Cancer.

[40]  K. Ghoshal,et al.  TGFβ mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3 , 2009, Oncogene.

[41]  Zhigang Xie.  Brain Tumor Stem Cells , 2009, Neurochemical Research.

[42]  P. Kleihues,et al.  IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas , 2009, Clinical Cancer Research.

[43]  Zhiwei Wang,et al.  Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. , 2009, Cancer research.

[44]  D. Pearson,et al.  IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. , 2009, Neuro-oncology.

[45]  K. Hoang-Xuan,et al.  Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas. , 2009, Neuro-oncology.

[46]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[47]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[48]  David T. W. Jones,et al.  Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. , 2008, Cancer research.

[49]  Junxia Zhang,et al.  hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells , 2008, Brain Research.

[50]  M. Comalada,et al.  IFN-{gamma}-mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation. , 2008, Blood.

[51]  M. Sánchez-Martín.  Brain tumour stem cells: implications for cancer therapy and regenerative medicine. , 2008, Current stem cell research & therapy.

[52]  E. Jordanova,et al.  Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival , 2008, Modern Pathology.

[53]  Y. Pekarsky,et al.  The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. , 2007, Best practice & research. Clinical haematology.

[54]  B. Scheithauer,et al.  The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.

[55]  S. K. Nagahashi Marie,et al.  Expression of HOXC9 and E2F2 are up-regulated in CD133(+) cells isolated from human astrocytomas and associate with transformation of human astrocytes. , 2007, Biochimica et biophysica acta.

[56]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[57]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[58]  A. Nakao,et al.  Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor. , 2006, Journal of neurosurgery.

[59]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[60]  A. Scorilas,et al.  Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy. , 2005, Anticancer research.

[61]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[62]  Wei Wu,et al.  Glucocorticoid Receptor-induced MAPK Phosphatase-1 (MPK-1) Expression Inhibits Paclitaxel-associated MAPK Activation and Contributes to Breast Cancer Cell Survival* , 2005, Journal of Biological Chemistry.

[63]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[64]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[65]  R. Wechsler-Reya,et al.  Getting at the Root and Stem of Brain Tumors , 2004, Neuron.

[66]  Daniel H. Geschwind,et al.  Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[68]  D. Steindler,et al.  Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro , 2002, Glia.

[69]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[70]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[71]  L. Rorke.  Pathologic diagnosis as the gold standard , 1997, Cancer.

[72]  J. Pichler,et al.  Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO). , 2013, Neuro-oncology.

[73]  R. Dahiya,et al.  MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. , 2012, Carcinogenesis.

[74]  Y. Mao,et al.  Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas. , 2011, Cancer biomarkers : section A of Disease markers.

[75]  J. Haier,et al.  MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. , 2010, European journal of cancer.

[76]  C. Altaner,et al.  Glioblastoma and stem cells. , 2008, Neoplasma.

[77]  J. Mora,et al.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. , 2007, Cancer cell.

[78]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .